| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSB2101002 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-18 | Shenyang Sunshine Pharmaceutical Co Ltd | view | |||
| CXSB2200096 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2022-11-08 | Shenyang Sunshine Pharmaceutical Co Ltd | view |